• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stratasys Releases Third Quarter 2023 Financial Results

    11/16/23 7:30:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology
    Get the next $SSYS alert in real time by email
    • Revenue of $162.1 million, essentially flat with third quarter 2022, up 3.3% at constant currency excluding MakerBot and Stratasys Direct divestments
    • Record-level recurring revenue for consumables reflects strong printer utilization
    • GAAP net loss of $47.3 million, or $0.68 per diluted share, and non-GAAP net income of $2.4 million, or $0.04 per diluted share
    • Ninth straight quarter of adjusted profitability
    • Updating 2023 outlook

    Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced financial results for the third quarter 2023.

    Third Quarter 2023 Financial Results Compared to Third Quarter 2022:

    • Revenue of $162.1 million compared to $162.2 million.
    • GAAP gross margin of 40.5%, compared to 43.6%.
    • Non-GAAP gross margin of 48.3%, compared to 48.5%.
    • GAAP operating loss of $42.8 million, which includes $17.3 million of costs related to merger and acquisition activities, defense against hostile tender offer, proxy contest and related professional fees, compared to an operating loss of $15.6 million.
    • Non-GAAP operating income of $4.1 million, compared to $4.5 million.
    • GAAP net loss of $47.3 million, or $0.68 per diluted share, compared to net income of $18.7 million, or $0.28 per diluted share, which net income in Q3 2022 included a one-time $39.1M gain from the MakerBot deconsolidation.
    • Non-GAAP net income of $2.4 million, or $0.04 per diluted share, compared to $3.3 million, or $0.05 per diluted share.
    • Adjusted EBITDA of $9.8 million, compared to $9.9 million.
    • Cash used in operations of $12.7 million, compared to $18.4 million in the year-ago quarter, due to the costs related to mergers and acquisitions activities, defense against a hostile tender offer, a proxy contest and related professional fees. Excluding these one-time payments, operating cash flow for the third quarter of 2023 would have been positive.

    Dr. Yoav Zeif, Stratasys' Chief Executive Officer stated, "During the third quarter, Stratasys delivered solid operating and financial results, highlighted by record recurring revenues from consumables, reflecting solid printer utilization. Our relentless focus on execution allowed us to deliver comparable results to the year-ago quarter for revenues, non-GAAP margins and adjusted EBITDA, as well as our ninth consecutive quarter of positive adjusted earnings per share."

    Dr. Zeif continued, "We want to acknowledge the tremendous support we have received from partners, customers, investors and our industry since the tragic events in Israel. We especially want to thank our employees who have performed in an exemplary fashion during these challenging times. Our operations have been fully functional, allowing us to continue delivering industry-leading results. We have streamlined and focused our business, while simultaneously rolling out new and exciting innovations that will expand our leadership position across systems, materials, software and customer service. Our recently introduced F3300 is the latest step in that continued evolution to unlock manufacturing benefits for our customers. Our maturity as a company, financial discipline and resilient business model position us well to deliver exceptional value for many years to come."

    2023 Financial Outlook:

    Based on the divestitures in Stratasys Direct, as well as macroeconomic uncertainty in its end markets, the Company is updating its revenue guidance and its outlook for the remainder of 2023 as follows:

    • Full year revenue of $620 million to $630 million.
    • Full year non-GAAP gross margins of 48.0% to 49.0%.
    • Full year non-GAAP operating expenses in a range of $288 million to $290 million.
    • Full year non-GAAP operating margins in a range of 2.0% to 2.5%.
    • GAAP net loss of $117 million to $104 million, or ($1.70) to ($1.51) per diluted share.
    • Includes one-time extraordinary costs associated with defense of tender offer and proxy contest, and merger-related activities.
    • Non-GAAP net income of $6 million to $9 million, or $0.10 to $0.14 per diluted share.
    • Adjusted EBITDA of $35 million to $38 million.
    • Capital expenditures of $15 million to $20 million.

    2023 non-GAAP earnings guidance excludes $112 million to $121 million of expenses attributable to projected amortization of intangible assets, share-based compensation expense, and reorganization and other expenses (including the one-time extraordinary costs referenced above). 2023 non-GAAP guidance includes tax adjustments of $2 million to $3 million on the above non-GAAP items.

    Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

    Stratasys Ltd. Third Quarter 2023 Webcast and Conference Call Details

    The Company plans to webcast its conference call to discuss its third quarter 2023 financial results on Thursday, November 16, 2023, at 10:00 a.m. (ET).

    The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:

    https://event.choruscall.com/mediaframe/webcast.html?webcastid=bSk6aoYV

    To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

    Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world's leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

    To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X.com (formerly Twitter), LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company's websites, to share material, non-public information pursuant to the SEC's Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

    Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

    Cautionary Statement Regarding Forward-Looking Statements

    The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2023 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; the outcome of our board's comprehensive process to explore strategic alternatives for our company; the degree to which our company's operations remain resistant to potential adverse effects of Israel's war against the terrorist organization Hamas; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the global macro-economic environment, including headwinds caused by inflation, high interest rates, unfavorable currency exchange rates and potential recessionary conditions; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D "Key Information - Risk Factors", Item 4, "Information on the Company", Item 5, "Operating and Financial Review and Prospects," and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2022, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 3, 2023 (the "2022 Annual Report"). Readers are urged to carefully review and consider the various disclosures made throughout our 2022 Annual Report and the Report of Foreign Private Issuer on Form 6-K that attaches Stratasys' unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition for the third quarter and first nine months of 2023, which will be furnished to the SEC on or about the date hereof, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    Use of Non-GAAP Financial Measures

    The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

    Stratasys Ltd.
     
    Consolidated Balance Sheets
    (Unaudited)
    (in thousands, except share data)
    September 30, December 31,

    2023

    2022

     
     
    ASSETS
     
    Current assets
    Cash and cash equivalents $

    104,563

    $

    150,470

     

    Short-term deposits

    80,000

     

    177,367

     

    Accounts receivable, net of allowance for credit losses of $1.4 million and $0.9 million

     

     

     

     

    as of September 30, 2023 and December 31, 2022, respectively

    164,075

    144,739

    Inventories

    197,420

     

    194,054

     

    Prepaid expenses

    9,732

     

    5,767

     

    Other current assets

    27,534

     

    27,823

     

     

     
    Total current assets

    583,324

     

    700,220

     

     

     
    Non-current assets

     

    Property, plant and equipment, net

    198,272

     

    195,063

     

    Goodwill

    90,187

     

    64,953

     

    Other intangible assets, net

    141,201

     

    121,402

     

    Operating lease right-of-use assets

    19,533

     

    18,122

     

    Long-term investments

    129,738

     

    141,610

     

    Other non-current assets

    19,510

     

    18,420

     

     

     
    Total non-current assets

    598,441

     

    559,570

     

     

     
    Total assets $

    1,181,765

    $

    1,259,790

     

     

     
    LIABILITIES AND EQUITY

     

     

     
    Current liabilities

     

    Accounts payable $

    60,845

    $

    72,921

     

    Accrued expenses and other current liabilities

    49,817

     

    45,912

     

    Accrued compensation and related benefits

    31,502

     

    34,432

     

    Deferred revenues - short term

    51,751

     

    50,220

     

    Operating lease liabilities - short term

    6,511

     

    7,169

     

     

     
    Total current liabilities

    200,426

     

    210,654

     

     

     
    Non-current liabilities

     

    Deferred revenues - long term

    28,559

     

    25,214

     

    Deferred income taxes - long term

    6,889

     

    5,638

     

    Operating lease liabilities - long term

    12,692

     

    10,670

     

    Contingent consideration

    25,884

     

    23,707

     

    Other non-current liabilities

    24,172

     

    24,475

     

     

     
    Total non-current liabilities

    98,196

     

    89,704

     

     

     
    Total liabilities

    298,622

     

    300,358

     

     

     
    Equity

     

    Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands

     

    shares; 69,165 shares and 67,086 shares issued and

     

    outstanding at September 30, 2023 and December 31, 2022, respectively

    194

     

    187

     

    Additional paid-in capital

    3,080,877

     

    3,048,915

     

    Accumulated other comprehensive loss

    (12,958

    )

     

    (12,818

    )

    Accumulated deficit

    (2,184,970

    )

     

    (2,076,852

    )

    Total equity

    883,143

     

    959,432

     

     

     
    Total liabilities and equity $

    1,181,765

    $

    1,259,790

     

    Stratasys Ltd.                
                      
    Consolidated Statements of Operations                
                      
    (in thousands, except per share data)                
                      
         Three Months Ended September 30,   Nine Months Ended September 30,
        

    2023

     

    2022

     

    2023

     

    2022

         (unaudited)   (unaudited)   (unaudited)   (unaudited)
    Net sales                
       Products  

     $

                           113,270

     

     

     $

      112,133

     

     

     $

                           323,353

     

     

     $

                    340,927

     

       Services  

     

                                48,863

     

     

     

           50,059

     

     

     

                              147,908

     

     

     

                       151,297

     

     

     

                              162,133

     

     

     

         162,192

     

     

     

                              471,261

     

     

     

                       492,224

     

                   
    Cost of sales                
       Products  

     

                                59,546

     

     

     

           55,916

     

     

     

                              168,235

     

     

     

                       176,421

     

       Services  

     

                                36,938

     

     

     

           35,527

     

     

     

                              105,760

     

     

     

                       107,984

     

       

     

                                96,484

     

     

     

           91,443

     

     

     

                              273,995

     

     

     

                       284,405

     

                   
    Gross profit  

     

                                65,649

     

     

     

           70,749

     

     

     

                              197,266

     

     

     

                       207,819

     

                   
    Operating expenses                
       Research and development, net  

     

                                23,567

     

     

     

           23,145

     

     

     

                                69,347

     

     

     

                        71,489

     

       Selling, general and administrative  

     

                                84,880

     

     

     

           63,230

     

     

     

                              221,173

     

     

     

                       195,085

     

     

     

                              108,447

     

     

     

           86,375

     

     

     

                              290,520

     

     

     

                       266,574

     

                   
    Operating loss  

     

                               (42,798

    )

     

     

          (15,626

    )

     

     

                               (93,254

    )

     

     

                       (58,755

    )

                     
    Gain from deconsolidation of subsidiary  

     

                                       -

     

     

     

    39,136

     

     

     

                                       -

     

     

     

                        39,136

     

       Financial income (expenses), net  

     

                                     687

     

     

     

                452

     

     

     

                                  2,147

     

     

     

                         (2,080

    )

                   
    Income (loss) before income taxes  

     

                               (42,111

    )

     

     

           23,962

     

     

     

                               (91,107

    )

     

     

                       (21,699

    )

                     
       Income tax expenses  

     

                                   (645

    )

     

     

           (3,298

    )

     

     

                                (5,145

    )

     

     

                         (2,796

    )

                   
       Share in losses of associated companies  

     

                                (4,523

    )

     

     

           (1,915

    )

     

     

                               (11,866

    )

     

     

                         (2,089

    )

                     
    Net income (loss)  

     $

                            (47,279

    )

     

     $

        18,749

     

     

     $

                          (108,118

    )

     

     $

                    (26,584

    )

                   
    Net income (loss) per share                 
    Basic  

     $

                               (0.68

    )

     

     $

            0.28

     

     

     $

                               (1.58

    )

     

     $

                        (0.40

    )

    Diluted  

     $

                               (0.68

    )

     

     $

            0.28

     

     

     $

                               (1.58

    )

     

     $

                        (0.40

    )

                   
    Weighted average ordinary shares outstanding                
    Basic  

     

                                69,093

     

     

     

           66,772

     

     

     

                                68,432

     

     

     

                        66,356

     

    Diluted  

     

                                69,093

     

     

     

           67,038

     

     

     

                                68,432

     

     

     

                        66,356

     

                   
    Three Months Ended September 30,

    2023

     

    Non-GAAP

     

    2023

     

    2022

     

    Non-GAAP

     

    2022

    GAAP Adjustments Non-GAAP GAAP Adjustments Non-GAAP
    U.S. dollars and shares in thousands (except per share amounts)
    Gross profit (1)

     $

            65,649

     

     $

            12,617

     $

            78,266

     $

                    70,749

     

     $

              7,990

     

     $

                 78,739

    Operating income (loss)  (1,2)

     

             (42,798

    )

     

               46,885

     $

              4,087

     

                     (15,626

    )

     

               20,149

     

     

                       4,523

    Net income (loss) (1,2,3)

     

             (47,279

    )

     

               49,725

     $

              2,446

     

                       18,749

     

     

             (15,423

    )

     

                       3,326

    Net income (loss) per diluted share (4)

     $

               (0.68

    )

     $

                 0.72

     $

                 0.04

     $

                        0.28

     

     $

               (0.23

    )

     $

                      0.05

    (1)

    Acquired intangible assets amortization expense   

     

                  5,142

     

                  6,941

     

    Non-cash stock-based compensation expense   

     

                     891

     

                  1,061

     

    Restructuring and other related costs   

     

                  6,584

     

                     (12

    )

     

               12,617

     

                  7,990

     

     

    (2)

    Acquired intangible assets amortization expense   

     

                  2,599

     

                  2,138

     

    Non-cash stock-based compensation expense   

     

                  6,588

     

                  6,330

     

    Restructuring and other related costs   

     

                  2,360

     

                  1,309

     

    Revaluation of investments

     

                  4,300

     

                     901

     

    Contingent consideration

     

                     265

     

                     394

     

    Legal, consulting and other expenses   

     

               18,156

     

                  1,087

     

     

               34,269

     

               12,159

     

     

               46,885

     

               20,149

     

     

    (3)

    Corresponding tax effect   

     

                     153

     

                  2,993

     

    Finance expenses

     

                     162

     

                        -

     

    Equity method related amortization and other

     

                  2,525

     

                     571

     

    Gain from deconsolidation of Subsidiary 

     

             (39,136

    )

     $

            49,725

     $

          (15,423

    )

     

    (4)

    Weighted average number of ordinary

    shares outstanding- Diluted

    69,093

    69,815

    67,038

    67,038

     
    Nine Months Ended September 30,

    2023

     

    Non-GAAP

     

    2023

     

    2022

     

    Non-GAAP

     

    2022

    GAAP Adjustments Non-GAAP GAAP Adjustments Non-GAAP
    U.S. dollars and shares in thousands (except per share amounts)
    Gross profit (1)

     $

          197,266

     

     $

            29,199

     $

          226,465

     $

                  207,819

     

     $

            27,593

     $

               235,412

    Operating income (loss)  (1,2)

     

             (93,254

    )

     

             103,866

     $

            10,612

     

                     (58,755

    )

     

               67,235

     $

                   8,480

    Net income (loss)  (1,2,3)

     

           (108,118

    )

     

             114,179

     $

              6,061

     

                     (26,584

    )

     

               32,295

     $

                   5,711

    Net income (loss) per diluted share (4)

     $

               (1.58

    )

     $

                 1.67

     $

                 0.09

     $

                      (0.40

    )

     $

                 0.49

     $

                      0.09

    (1)

    Acquired intangible assets amortization expense   

     

               14,157

     

               20,861

     

     

    Non-cash stock-based compensation expense   

     

                  2,822

     

                  3,041

     

     

    Restructuring and other related costs   

     

               12,220

     

                  3,691

     

     

     

               29,199

     

               27,593

     

     

     

    (2)

    Acquired intangible assets amortization expense   

     

                  7,479

     

                  6,581

     

     

    Non-cash stock-based compensation expense   

     

               20,920

     

               21,714

     

     

    Restructuring and other related costs   

     

                  6,626

     

                  1,864

     

     

    Revaluation of investments

     

                  4,880

     

                  3,217

     

     

    Contingent consideration

     

                     877

     

                  1,197

     

     

    Legal, consulting and other expenses   

     

               33,885

     

                  5,069

     

     

     

               74,667

     

               39,642

     

     

     

             103,866

     

               67,235

     

     

     

    (3)

    Corresponding tax effect   

     

                  3,404

     

                  3,219

     

     

    Finance expenses

     

                  1,827

     

                     571

     

     

    Equity method related amortization and other

     

                  5,081

     

                     406

     

     

    Gain from deconsolidation of Subsidiary 

     

                        -  

     

             (39,136

    )

     

     $

          114,179

     $

            32,295

     

     

     

    (4)

    Weighted average number of ordinary

    shares outstanding- Diluted

               68,432

               69,046

    66,356

    67,007

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231116140798/en/

    Get the next $SSYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SSYS

    DatePrice TargetRatingAnalyst
    2/13/2024$24.00Overweight
    Cantor Fitzgerald
    1/4/2023$15.00Hold → Buy
    Needham
    11/8/2022Underperform → Mkt Perform
    William Blair
    8/17/2022$24.00Outperform
    Credit Suisse
    5/17/2022$25.00 → $23.00Underweight → Neutral
    JP Morgan
    2/24/2022$30.00Hold → Buy
    Cross Research
    11/4/2021Neutral → Underweight
    JP Morgan
    11/4/2021Overweight → Neutral
    JP Morgan
    More analyst ratings

    $SSYS
    SEC Filings

    View All

    SEC Form 6-K filed by Stratasys Ltd.

    6-K - STRATASYS LTD. (0001517396) (Filer)

    11/13/25 11:53:46 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    SEC Form 6-K filed by Stratasys Ltd.

    6-K - STRATASYS LTD. (0001517396) (Filer)

    11/13/25 7:54:01 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    SEC Form 6-K filed by Stratasys Ltd.

    6-K - STRATASYS LTD. (0001517396) (Filer)

    9/30/25 4:38:51 PM ET
    $SSYS
    Computer peripheral equipment
    Technology

    $SSYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hawk Ridge Systems Adds Stratasys Technologies to Its 3D Printing Portfolio

    Broadening additive manufacturing possibilities with advanced capabilities and scalability Hawk Ridge Systems is proud to announce a new partnership with Stratasys (NASDAQ:SSYS), a global leader in polymer additive manufacturing, to expand its 3D printing solutions. This partnership broadens Hawk Ridge Systems' manufacturing portfolio with production-grade technologies that offer advanced prototyping, tooling and end-use manufacturing applications to customers across several industries, such as aerospace, automotive, medical and dental, industrial equipment and consumer markets. Together, the companies can reach more manufacturers and support real-world, production-ready applications

    2/5/26 6:14:00 PM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys Begins Qualification of SAF™ PA12 Production-Ready Nylon for Key Industrial Use Cases

    Industry partners, including Boeing, GA-ASI, Northrop Grumman, and Raytheon aim to validate SAF to address modernization and reshoring supply chain initiatives for scalable, qualified manufacturing Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of a qualification program of SAF™ PA12, a production-ready nylon material, designed to help manufacturers apply selective absorption fusion technology across key aerospace and industrial use cases. This program is intended to help manufacturers address modernization and reshoring initiatives by enabling more scalable, qualified additive manufacturing. This press release features multimedia. View the full release here: https://www.busines

    2/3/26 8:15:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys Launches Post Processing Partnership Program to Improve the Customer Experience by Simplifying Additive Manufacturing Workflows

    PostProcess Technologies named first partner under new program, expanding customer access to validated post-processing solutions Stratasys (NASDAQ:SSYS) today announced the launch of its new Post Processing Partnership Program, a strategic initiative designed to simplify how customers access validated post-processing solutions as part of complete, end-to-end additive manufacturing workflows. As part of the program's launch, Stratasys also announced a new commercial agreement with PostProcess Technologies, a leader in automated and intelligent post-printing solutions for additive manufacturing, making it the first partner to participate in the program. This press release features multimed

    1/27/26 8:15:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    $SSYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Stratasys with a new price target

    Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00

    2/13/24 6:45:02 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys upgraded by Needham with a new price target

    Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00

    1/4/23 7:56:13 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys upgraded by William Blair

    William Blair upgraded Stratasys from Underperform to Mkt Perform

    11/8/22 7:27:14 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    $SSYS
    Leadership Updates

    Live Leadership Updates

    View All

    Stratasys Digital Anatomy™ Technology Powers First 3D-Printed Eyelid Surgery Training Models in Europe

    Addion and the University of Innsbruck advance surgical education with life-like anatomical models that enhance the skill sets of medical professionals and improve patient outcomes Stratasys Ltd. (NASDAQ:SSYS) today announced that Austrian medical training and innovation company, Addion GmbH, together with Eyecer.at Gmbh, has adopted a Stratasys Digital Anatomy™ Solution to create Europe's first 3D-printed anatomical eye models for eyelid surgery training. The solution, already implemented by the Anatomical Institute of the University of Innsbruck, enables surgeons and medical students to practice delicate procedures with exceptional accuracy and realism, supporting better outcomes for bo

    11/18/25 8:15:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Sunbit Appoints Shai Terem as Chief Financial Officer to Support Next Stage of Growth

    Former public company CEO brings deep capital markets, strategic, and operational experience Sunbit, the company building financial technology for real life, today announced the appointment of Shai Terem as Chief Financial Officer. Terem brings more than 15 years of executive leadership spanning growth strategy, financial operations, and capital markets, which will be instrumental as Sunbit continues to scale its platform and prepares for its next phase of growth and maturity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916917600/en/Sunbit CFO Shai Terem Terem most recently served as President and CEO of Markforged (NYSE

    9/16/25 8:00:00 AM ET
    $KRNT
    $MKFG
    $SSYS
    Industrial Machinery/Components
    Industrials
    Computer peripheral equipment
    Technology

    Stratasys Closes $120 Million Strategic Investment by Fortissimo Capital

    Further bolsters strong balance sheet Positions company for future growth through strategic investments to further enhance industry leadership Appoints Yuval Cohen to Board of Directors Stratasys Ltd. (NASDAQ:SSYS) ("the Company"), a leader in polymer 3D printing solutions, today announced the closing of a $120 million strategic investment by Fortissimo Capital ("Fortissimo"), a leading Israeli private equity fund investing in technology and industrials. As part of the closing of the investment, Fortissimo has acquired approximately 14% of Stratasys' issued and outstanding ordinary shares through a direct purchase of 11,650,485 newly issued ordinary shares at $10.30 per share. As a resul

    4/10/25 4:30:00 PM ET
    $SSYS
    Computer peripheral equipment
    Technology

    $SSYS
    Financials

    Live finance-specific insights

    View All

    Stratasys Releases Third Quarter 2025 Financial Results

    Revenue of $137.0 million, compared to $140.0 million in the prior year period GAAP net loss of $55.6 million, or $0.65 per diluted share (includes non-cash impairment of $33.9 million, or $0.40 per share) and non-GAAP net income of $1.5 million, or $0.02 per diluted share Adjusted EBITDA of $5.0 million, compared to $5.1 million in the prior year period Generated $6.9 million in operational cash flow, compared to $4.5 million of cash used in the prior year period $255.0 million cash, equivalents and short-term deposits and no debt at September 30, 2025 Reiterating non-GAAP outlook and adjusting GAAP Net Income and EPS due to the above-referenced non-cash impairment Strat

    11/13/25 7:30:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys Conference Call to Discuss Third Quarter 2025 Financial Results

    Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025. The Company plans to hold the conference call to discuss its third quarter 2025 financial results on Thursday, November 13, 2025, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=utWHBI2d To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at leas

    10/30/25 7:00:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Stratasys Releases Second Quarter 2025 Financial Results

    Revenue of $138.1 million, compared to $138.0 million in the prior year period GAAP net loss of $16.7 million, or $0.20 per diluted share, and non-GAAP net income of $2.2 million, or $0.03 per diluted share Adjusted EBITDA of $6.1 million, compared to $2.3 million in the prior year period $254.6 million cash, equivalents and short-term deposits and no debt at June 30, 2025 Updates 2025 Outlook Stratasys Ltd. (NASDAQ:SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the second quarter ended June 30, 2025. "Our results once again reflect resilience from our recurring revenue streams and the reliance customers place on our additive ma

    8/13/25 7:00:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    $SSYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/14/24 6:18:58 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/13/24 4:30:24 PM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/5/24 5:11:59 PM ET
    $SSYS
    Computer peripheral equipment
    Technology